Literature DB >> 24093462

The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study.

R Sprengelmeyer1, M Orth1, H-P Müller1, R C Wolf2, G Grön3, M S Depping2, J Kassubek1, D Justo4, E M Rees5, S Haider5, J H Cole5, N Z Hobbs5, R A C Roos6, A Dürr4, S J Tabrizi5, S D Süssmuth1, G B Landwehrmeyer1.   

Abstract

BACKGROUND: Depressive symptoms are prominent psychopathological features of Huntington's disease (HD), making a negative impact on social functioning and well-being.
METHOD: We compared the frequencies of a history of depression, previous suicide attempts and current subthreshold depression between 61 early-stage HD participants and 40 matched controls. The HD group was then split based on the overall HD group's median Hospital Anxiety and Depression Scale-depression score into a group of 30 non-depressed participants (mean 0.8, s.d. = 0.7) and a group of 31 participants with subthreshold depressive symptoms (mean 7.3, s.d. = 3.5) to explore the neuroanatomy underlying subthreshold depressive symptoms in HD using voxel-based morphometry (VBM) and diffusion tensor imaging (DTI).
RESULTS: Frequencies of history of depression, previous suicide attempts or current subthreshold depressive symptoms were higher in HD than in controls. The severity of current depressive symptoms was also higher in HD, but not associated with the severity of HD motor signs or disease burden. Compared with the non-depressed HD group DTI revealed lower fractional anisotropy (FA) values in the frontal cortex, anterior cingulate cortex, insula and cerebellum of the HD group with subthreshold depressive symptoms. In contrast, VBM measures were similar in both HD groups. A history of depression, the severity of HD motor signs or disease burden did not correlate with FA values of these regions.
CONCLUSIONS: Current subthreshold depressive symptoms in early HD are associated with microstructural changes - without concomitant brain volume loss - in brain regions known to be involved in major depressive disorder, but not those typically associated with HD pathology.

Entities:  

Mesh:

Year:  2013        PMID: 24093462     DOI: 10.1017/S003329171300247X

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  15 in total

1.  Viral vector mediated expression of mutant huntingtin in the dorsal raphe produces disease-related neuropathology but not depressive-like behaviors in wildtype mice.

Authors:  Mark Pitzer; Jordan Lueras; Anna Warden; Sydney Weber; Jodi McBride
Journal:  Brain Res       Date:  2015-02-28       Impact factor: 3.252

2.  Intrinsic mutant HTT-mediated defects in oligodendroglia cause myelination deficits and behavioral abnormalities in Huntington disease.

Authors:  Costanza Ferrari Bardile; Marta Garcia-Miralles; Nicholas S Caron; Nirmala Arul Rayan; Sarah R Langley; Nathan Harmston; Ana Maria Rondelli; Roy Tang Yi Teo; Sabine Waltl; Lisa M Anderson; Han-Gyu Bae; Sangyong Jung; Anna Williams; Shyam Prabhakar; Enrico Petretto; Michael R Hayden; Mahmoud A Pouladi
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-23       Impact factor: 11.205

3.  Motor network structure and function are associated with motor performance in Huntington's disease.

Authors:  Hans-Peter Müller; Martin Gorges; Georg Grön; Jan Kassubek; G Bernhard Landwehrmeyer; Sigurd D Süßmuth; Robert Christian Wolf; Michael Orth
Journal:  J Neurol       Date:  2016-01-13       Impact factor: 4.849

4.  Cognitive and autonomic dysfunction in presymptomatic and early Huntington's disease.

Authors:  Jan Kobal; Ziva Melik; Ksenija Cankar; Martin Strucl
Journal:  J Neurol       Date:  2014-04-02       Impact factor: 4.849

Review 5.  Insights into the Pathophysiology of Psychiatric Symptoms in Central Nervous System Disorders: Implications for Early and Differential Diagnosis.

Authors:  Giulia Menculini; Elena Chipi; Federico Paolini Paoletti; Lorenzo Gaetani; Pasquale Nigro; Simone Simoni; Andrea Mancini; Nicola Tambasco; Massimiliano Di Filippo; Alfonso Tortorella; Lucilla Parnetti
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 6.  Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.

Authors:  Claudia Rangel-Barajas; George V Rebec
Journal:  J Huntingtons Dis       Date:  2016-12-15

7.  Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease.

Authors:  Peter McColgan; Adeel Razi; Sarah Gregory; Kiran K Seunarine; Alexandra Durr; Raymund A C Roos; Blair R Leavitt; Rachael I Scahill; Chris A Clark; Doug R Langbehn; Geraint Rees; Sarah J Tabrizi
Journal:  Hum Brain Mapp       Date:  2017-03-15       Impact factor: 5.038

8.  Irritability in Huntington's Disease: Factor Analysis of Snaith's Irritability Scale.

Authors:  John Maltby; Maria Dale; Mandy Underwood; Jane Simpson
Journal:  Mov Disord Clin Pract       Date:  2016-10-01

9.  Neuropsychiatry and White Matter Microstructure in Huntington's Disease.

Authors:  Sarah Gregory; Rachael I Scahill; Kiran K Seunarine; Cheryl Stopford; Hui Zhang; Jiaying Zhang; Michael Orth; Alexandra Durr; Raymund A C Roos; Douglas R Langbehn; Jeffrey D Long; Hans Johnson; Geraint Rees; Sarah J Tabrizi; David Craufurd
Journal:  J Huntingtons Dis       Date:  2015

10.  Structural and molecular myelination deficits occur prior to neuronal loss in the YAC128 and BACHD models of Huntington disease.

Authors:  Roy Tang Yi Teo; Xin Hong; Libo Yu-Taeger; Yihui Huang; Liang Juin Tan; Yuanyun Xie; Xuan Vinh To; Ling Guo; Reshmi Rajendran; Arianna Novati; Carsten Calaminus; Olaf Riess; Michael R Hayden; Huu P Nguyen; Kai-Hsiang Chuang; Mahmoud A Pouladi
Journal:  Hum Mol Genet       Date:  2016-04-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.